
SkinHealth Systems Inc.: updates and filings
Price
$11.77
November 20, 2026
What Ploutos Investor adds for SkinHealth Systems
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
October 2026
September 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 9, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operationsForm8-K
- Nov 5, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 14, 2026Change to shareholders' rights, amended articles or bylaws, Regulation FD disclosureForm8-K
- Oct 6, 2026Material agreement ended, Regulation FD disclosureForm8-K
- Sep 28, 2026Shareholder voteForm8-K
- Sep 10, 2026Officer or director changeForm8-K
- Aug 14, 2026Officer or director changeForm8-K
- Aug 12, 2026Additional annual meeting materialFormDEFA14A
- Aug 12, 2026Annual meeting proxy statementFormDEF 14A
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jul 31, 2026Preliminary proxy statementFormPRE 14A
- Jul 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 17, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 8, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jun 22, 2026Other material eventsForm8-K
- Jun 16, 2026Shareholder voteForm8-K
- May 21, 2026Officer or director change (amendment)Form8-K/A
- May 12, 2026Delisting noticeForm8-K
- May 11, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 7, 2026Results of operationsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 9, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations | Document |
| Nov 5, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 14, 2026 | 8-K | Change to shareholders' rights, amended articles or bylaws, Regulation FD disclosure | Document |
| Oct 6, 2026 | 8-K | Material agreement ended, Regulation FD disclosure | Document |
| Sep 28, 2026 | 8-K | Shareholder vote | Document |
| Sep 10, 2026 | 8-K | Officer or director change | Document |
| Aug 14, 2026 | 8-K | Officer or director change | Document |
| Aug 12, 2026 | DEFA14A | Additional annual meeting material | Document |
| Aug 12, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jul 31, 2026 | PRE 14A | Preliminary proxy statement | Document |
| Jul 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 17, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 8, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jun 22, 2026 | 8-K | Other material events | Document |
| Jun 16, 2026 | 8-K | Shareholder vote | Document |
| May 21, 2026 | 8-K/A | Officer or director change (amendment) | Document |
| May 12, 2026 | 8-K | Delisting notice | Document |
| May 11, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 7, 2026 | 8-K | Results of operations | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Aug 12, 2020.
The full analysis
What do SkinHealth Systems's filings show?
The filings are where every one of SkinHealth Systems's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.